The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Homocysteine and Dementia: An International Consensus Statement
Open accessAbstract
Identification of modifiable risk factors provides a crucial approach to the prevention of dementia. Nutritional or nutrient-dependent risk factors are especially important because dietary modifications or use of dietary supplements may lower the risk factor level. One such risk factor is a raised concentration of the biomarker plasma total homocysteine, which reflects the functional status of three B vitamins (folate, vitamins B12, B6). A group of experts reviewed literature evidence from the last 20 years. We here present a Consensus Statement, based on the Bradford Hill criteria, and conclude that elevated plasma total homocysteine is a modifiable risk factor for development of cognitive decline, dementia, and Alzheimer’s disease in older persons. In a variety of clinical studies, the relative risk of dementia in elderly people for moderately raised homocysteine (within the normal range) ranges from 1.15 to 2.5, and the Population Attributable risk ranges from 4.3 to 31%. Intervention trials in elderly with cognitive impairment show that homocysteine-lowering treatment with B vitamins markedly slows the rate of whole and regional brain atrophy and also slows cognitive decline. The findings are consistent with moderately raised plasma total homocysteine (>11 μmol/L), which is common in the elderly, being one of the causes of age-related cognitive decline and dementia. Thus, the public health significance of raised tHcy in the elderly should not be underestimated, since it is easy, inexpensive, and safe to treat with B vitamins. Further trials are needed to see whether B vitamin treatment will slow, or prevent, conversion to dementia in people at risk of cognitive decline or dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Self-citationFolate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
Self-citationCausation and Causal Inference in Epidemiology
Rothman, K. J., & Greenland, S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.059204 · Cited by 1,259
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
Self-citationROTHMAN, K. J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112335 · Cited by 776
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
Kruman, I. I., Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., Haughey, N., Lee, J., Evans, M., & Mattson, M. P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01752.2002 · Cited by 643
Meta-analysis of modifiable risk factors for Alzheimer's disease
Xu, W., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Zhao, Q.-F., Li, J.-Q., Wang, J., & Yu, J.-T. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310548 · Cited by 573
Aisen, P. S. (2008) · JAMA · doi:10.1001/jama.300.15.1774 · Cited by 557
Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment
Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., E. Nichols, T., Smith, S. M., & Smith, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301816110 · Cited by 515
Self-citationHomocysteine, B Vitamins, and Cognitive Impairment
Smith, A. D., & Refsum, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050947 · Cited by 513
Self-citationHomocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Self-citationObeid, R., & Herrmann, W. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.088 · Cited by 490
Self-citationTotal serum homocysteine in senile dementia of Alzheimer type
McCaddon, A., Davies, G., Hudson, P., Tandy, S., & Cattell, H. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199804)13:4<235::aid-gps761>3.0.co;2-8 · Cited by 398
Self-citationTucker, K. L., Qiao, N., Scott, T., Rosenberg, I., & Spiro, A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.627 · Cited by 351
Self-citationThe Role of Cdk5 in Alzheimer’s Disease
Liu, S.-L., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 269
The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?
Smith, A. D. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s119 · Cited by 216
Self-citationClarke, R., Bennett, D., Parish, S., Lewington, S., Skeaff, M., Eussen, S. J., Lewerin, C., Stott, D. J., Armitage, J., Hankey, G. J., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076349 · Cited by 204
Jernerén, F., Elshorbagy, A. K., Oulhaj, A., Smith, S. M., Refsum, H., & Smith, A. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103283 · Cited by 189
Self-citationIs hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?
Zhuo, J., Wang, H., & Praticò, D. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.003 · Cited by 166
Hyperhomocysteinemia and Alzheimer's disease: A systematic review
Van Dam, F., & Van Gool, W. A. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2008.03.009 · Cited by 162
Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study
Nurk, E., Refsum, H., Tell, G. S., Engedal, K., Vollset, S. E., Ueland, P. M., Nygaard, H. A., & Smith, A. D. (2005) · Annals of Neurology · doi:10.1002/ana.20645 · Cited by 161
Self-citationOulhaj, A., Jernerén, F., Refsum, H., Smith, A. D., & de Jager, C. A. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150777 · Cited by 159
Self-citationPlasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
Hooshmand, B., Polvikoski, T. M., Kivipelto, M., Tanskanen, M., Myllykangas, L., Erkinjuntti, T., Mäkelä, M., Oinas, M., Paetau, A. E., Scheltens, P., et al. (2013) · Brain · doi:10.1093/brain/awt206 · Cited by 135
Self-citationLi, J., Chu, J., Barrero, C. A., Merali, S., & Praticò, D. (2014) · Annals of Neurology · doi:10.1002/ana.24145 · Cited by 127
Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Oulhaj, A., Refsum, H., Beaumont, H., Williams, J. H., King, E., Jacoby, R. J., & Smith, A. D. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2303 · Cited by 125
Self-citationSerum homocysteine and dementia: Meta‐analysis of eight cohort studies including 8669 participants
Wald, D. S., Kasturiratne, A., & Simmonds, M. C. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.234 · Cited by 122
Shen, L., & Ji, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150140 · Cited by 119
Protein N-homocysteinylation: From cellular toxicity to neurodegeneration
Sharma, G. S., Kumar, T., Dar, T. A., & Singh, L. R. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.08.013 · Cited by 88
Chemical Biology of Homocysteine Thiolactone and Related Metabolites
Jakubowski, H., & Głowacki, R. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-387042-1.00005-8 · Cited by 80
Midlife homocysteine and late-life dementia in women. A prospective population study
Zylberstein, D. E., Lissner, L., Björkelund, C., Mehlig, K., Thelle, D. S., Gustafson, D., Östling, S., Waern, M., Guo, X., & Skoog, I. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.024 · Cited by 76
McCaddon, A., & Miller, J. W. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv022 · Cited by 69
Self-citationHomocysteine and Alzheimer’s Disease: Evidence for a Causal Link from Mendelian Randomization
Hu, Q., Teng, W.-H., Li, J.-J., Hao, F.-F., & Wang, N.-D. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150977 · Cited by 62
Obeid, R., Kasoha, M., Knapp, J.-P., Kostopoulos, P., Becker, G., Fassbender, K. C., & Herrmann, W. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.085241 · Cited by 55
Self-citationHyperhomocysteinemia: A New Risk Factor for Alzheimer Disease?
Diaz-Arrastia, R. R. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1407 · Cited by 42
Homocysteine and cognition – A historical perspective
McCaddon, A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9402 · Cited by 40
Self-citationHyperhomocysteinemia and Risk of Cognitive Decline: A Meta-Analysis of Prospective Cohort Studies
Nie, T., Lu, T., Xie, L., Huang, P., Lü, Y., & Jiang, M. (2014) · European Neurology · doi:10.1159/000363054 · Cited by 23
Homocysteine, antioxidant micronutrients and late onset dementia
Whalley, L. J., Duthie, S. J., Collins, A. R., Starr, J. M., Deary, I. J., Lemmon, H. A., Duthie, A. C., Murray, A. D., & Staff, R. T. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0526-6 · Cited by 23
Tsiachristas, A., & Smith, A. D. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.07.002 · Cited by 19
Self-citationAlzheimer‘s disease, oxidative stress and B-vitamin depletion
McCaddon, A., & Hudson, P. R. (2007) · Future Neurology · doi:10.2217/14796708.2.5.537 · Cited by 12
Self-citation
Cited by
Nutrition and prevention of cognitive impairment
Scarmeas, N., Anastasiou, C. A., & Yannakoulia, M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30338-7 · Cited by 612
Calderón‐Ospina, C. A., & Nava‐Mesa, M. O. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13207 · Cited by 530
Román, G. C., Jackson, R. E., Gadhia, R., Román, A. N., & Reis, J. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.08.005 · Cited by 421
Regulators of the transsulfuration pathway
Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14446 · Cited by 377
Homocysteine – from disease biomarker to disease prevention
Smith, A. D., & Refsum, H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13279 · Cited by 261
Self-citation
Metadata
- Authors
- Smith, A. D., Refsum, H., Bottiglieri, T., Fenech, M., Hooshmand, B., McCaddon, A., Miller, J. W., Rosenberg, I. H., & Obeid, R.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2018-02-20
- Volume
- 62
- Issue
- 2
- Pages
- 561-570
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2789200606
- Cited by
- 360
- References
- 44
- FWCI
- 26.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.